Evidence map›Paper›PMID 24771638›Full record

ArticleInternational journal of cancer2014

Quantitative proteome profiling of lymph node-positive vs. -negative colorectal carcinomas pinpoints MX1 as a marker for lymph node metastasis.

Roland S Croner, Michael Stürzl, Tilman T Rau, Gergana Metodieva, Carol I Geppert, Elisabeth Naschberger, Berthold Lausen, Metodi V Metodiev

Open access · bronzeAbstract read
In one paragraph

Article in International journal of cancer, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 19 papers.

0numbers the graph read from it
0cells of the map it votes in
19citing papers in PubMed
2.3field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

19 citing papers in PubMed, 29 citations in OpenAlex.

  1. CD86 is linked to apoptosis in canine histiocytic sarcoma.Frontiers in veterinary science · 2025
    Article
  2. Review
  3. Article
  4. Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. Review
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 2 countries.

Roland S CronerDepartment of Surgery, University Hospital Erlangen, Erlangen, Germany.
Michael Stürzl
Tilman T Rau
Gergana Metodieva
Carol I Geppert
Elisabeth Naschberger
Berthold Lausen
Metodi V Metodiev
Universitätsklinikum Erlangen · DEUniversity of Essex · GB

Funding

Identification of new markers and drug target candidates for triple negative breaR03CA150131 · NCI · UNIVERSITY OF ESSEX · PI METODIEV, METODI V · 2011 to 2012
$99k
NCI NIH HHS 1R03CA150131NCI NIH HHS R03 CA150131
6 · The paper itself

Abstract

We used high-resolution mass spectrometry to measure the abundance of more than 9,000 proteins in 19 individually dissected colorectal tumors representing lymph node metastatic (n = 10) and nonmetastatic (n = 9) phenotypes. Statistical analysis identified MX1 and several other proteins as overexpressed in lymph node-positive tumors. MX1, IGF1-R and IRF2BP1 showed significantly different expression in immunohistochemical validation (Wilcoxon test p = 0.007 for IGF1-R, p = 0.04 for IRF2BP1 and p = 0.02 for MX1 at the invasion front) in the validation cohort. Knockout of MX1 by siRNA in cell cultures and wound healing assays provided additional evidence for the involvement of this protein in tumor invasion. The collection of identified and quantified proteins to our knowledge is the largest tumor proteome dataset available at the present. The identified proteins can give insights into the mechanisms of lymphatic metastasis in colorectal carcinoma and may act as prognostic markers and therapeutic targets after further prospective validation.

Indexed as

ProteomeBiomarkers, TumorCarrier ProteinsChromatography, LiquidCohort StudiesColorectal NeoplasmsHumansImmunohistochemistryLymphatic MetastasisMass SpectrometryMyxovirus Resistance ProteinsNeoplasm InvasivenessPhenotypeProteomicsReceptor, IGF Type 1RNA, Small InterferingBiomarkers, TumorCarrier ProteinsIRF2BP1 protein, humanMX1 protein, humanMyxovirus Resistance ProteinsProteomeReceptor, IGF Type 1RNA, Small InterferingUbiquitin-Protein Ligasesbiomarkerscolorectal cancerdrug targetsmass spectrometrymetastasisMX1

Identifiers

PMID24771638
PMCPMC4192020
OpenAlexW2155020774

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.